Toxoplasma gondii IgG antibody immunoblotting kit and preparation method thereof
A technology of immunoblotting and toxoplasma gondii, applied in the field of kits, can solve problems such as high price and achieve the effects of low cost, strong specificity and high sensitivity
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
preparation example Construction
[0033] The preparation method of described toxoplasma gondii IgG antibody immunoblotting kit comprises the following steps:
[0034]1) Preparation of SAG1 (P30), SAG2 (P22), ROP2 and GRA7 Toxoplasma gondii recombinant antigens
[0035] Using gene cloning technology, PCR amplified the DNA encoding the T. gondii antigen, and inserted it into Escherichia coli to express it, and obtained the T. gondii recombinant antigens SAG1 (P30), SAG2 (P22), ROP2 and GRA7.
[0036] 2) Spotting on nitrocellulose membrane
[0037] SAG1 (P30), SAG2 (P22), ROP2 and GRA7 Toxoplasma recombinant antigens were coated on the nitrocellulose membrane IgG detection line, human IgG antibody was coated on the control line, and dried.
[0038] 3) Preparation of anti-human IgG specific fragment γ chain monoclonal antibody
[0039] Balb / c mice were immunized with human IgG specific fragment γ chain as antigen, and hybridoma cell lines stably secreting anti-human IgG monoclonal antibody were screened by hybri...
Embodiment 1
[0065] Paste the nitrocellulose membrane on the surface of the carrier plate, the Toxoplasma IgG antibody detection line and the control line are arranged on the nitrocellulose membrane in turn; the Toxoplasma IgG antibody detection line is coated with Toxoplasma recombinant antigen SAG1 (P30), SAG2 (P22 ), ROP2 and GRA7, coated with human IgG antibody at the control line, cut into strips with a strip cutter, and assembled with enzyme-labeled anti-human γ-chain monoclonal antibody and its substrate to form Toxoplasma gondii IgG antibody immunoblotting reagent box.
[0066] 1) The sample was diluted 1:50 with 0.01mol / LPBS buffer.
[0067] 2) Blocking: 5% skimmed milk powder (prepared with 0.01 mol / L PBST buffer) was used as the blocking solution, and incubated at room temperature (18-25° C.) on a rocking table for 30 min.
[0068] 3) Serum incubation: take out the required membrane strips, put them into the incubation tank, and number them. Add 1.5ml of the diluted sample to ...
Embodiment 2
[0076] Similar to Example 1, the difference is that the nitrocellulose membrane detection line only consists of SAG2 (P22), ROP2 and GRA7 Toxoplasma recombinant antigens, and does not contain SAG1 (P30) Toxoplasma recombinant antigens. Result judgment is identical with embodiment 1.
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com